These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20967453)

  • 1. Left ventricular dilation in toll-like receptor 2 deficient mice after myocardial ischemia/reperfusion through defective scar formation.
    Mersmann J; Habeck K; Latsch K; Zimmermann R; Jacoby C; Fischer JW; Hartmann C; Schrader J; Kirschning CJ; Zacharowski K
    Basic Res Cardiol; 2011 Jan; 106(1):89-98. PubMed ID: 20967453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody.
    Arslan F; Smeets MB; O'Neill LA; Keogh B; McGuirk P; Timmers L; Tersteeg C; Hoefer IE; Doevendans PA; Pasterkamp G; de Kleijn DP
    Circulation; 2010 Jan; 121(1):80-90. PubMed ID: 20026776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 2 signaling triggers fatal arrhythmias upon myocardial ischemia-reperfusion.
    Mersmann J; Koch A; Tran N; Zimmermann R; Granja TF; Larmann J; Herzog C; Theilmeier G; Bornstein SR; Kirschning CJ; Zacharowski K
    Crit Care Med; 2010 Oct; 38(10):1927-32. PubMed ID: 20855990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction.
    Favre J; Musette P; Douin-Echinard V; Laude K; Henry JP; Arnal JF; Thuillez C; Richard V
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1064-71. PubMed ID: 17332486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injury.
    Mersmann J; Berkels R; Zacharowski P; Tran N; Koch A; Iekushi K; Dimmeler S; Granja TF; Boehm O; Claycomb WC; Zacharowski K
    Crit Care Med; 2010 Mar; 38(3):903-9. PubMed ID: 20081527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biglycan is required for adaptive remodeling after myocardial infarction.
    Westermann D; Mersmann J; Melchior A; Freudenberger T; Petrik C; Schaefer L; Lüllmann-Rauch R; Lettau O; Jacoby C; Schrader J; Brand-Herrmann SM; Young MF; Schultheiss HP; Levkau B; Baba HA; Unger T; Zacharowski K; Tschöpe C; Fischer JW
    Circulation; 2008 Mar; 117(10):1269-76. PubMed ID: 18299507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction.
    Shishido T; Nozaki N; Yamaguchi S; Shibata Y; Nitobe J; Miyamoto T; Takahashi H; Arimoto T; Maeda K; Yamakawa M; Takeuchi O; Akira S; Takeishi Y; Kubota I
    Circulation; 2003 Dec; 108(23):2905-10. PubMed ID: 14656915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dynamic expression of toll like receptor 2 and 4 in a rat model of myocardial ischemia/reperfusion injury].
    Liu QP; Pan KY; Zhou X; Yu HL; Han GL; Li YM; Jiang TM; Zhang M
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Jul; 29(4):326-30. PubMed ID: 24175554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice.
    Oyama J; Blais C; Liu X; Pu M; Kobzik L; Kelly RA; Bourcier T
    Circulation; 2004 Feb; 109(6):784-9. PubMed ID: 14970116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 2 is protective of ischemia-reperfusion-mediated small-bowel injury in a murine model.
    Aprahamian CJ; Lorenz RG; Harmon CM; Dimmit RA
    Pediatr Crit Care Med; 2008 Jan; 9(1):105-9. PubMed ID: 17906593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion.
    Tada H; Kagaya Y; Takeda M; Ohta J; Asaumi Y; Satoh K; Ito K; Karibe A; Shirato K; Minegishi N; Shimokawa H
    Cardiovasc Res; 2006 Aug; 71(3):466-77. PubMed ID: 16781691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders.
    Honda T; Kaikita K; Tsujita K; Hayasaki T; Matsukawa M; Fuchigami S; Sugiyama S; Sakashita N; Ogawa H; Takeya M
    J Mol Cell Cardiol; 2008 May; 44(5):915-26. PubMed ID: 18436235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice.
    Braunersreuther V; Pellieux C; Pelli G; Burger F; Steffens S; Montessuit C; Weber C; Proudfoot A; Mach F; Arnaud C
    J Mol Cell Cardiol; 2010 Apr; 48(4):789-98. PubMed ID: 19665464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR2 has a detrimental role in mouse transient focal cerebral ischemia.
    Ziegler G; Harhausen D; Schepers C; Hoffmann O; Röhr C; Prinz V; König J; Lehrach H; Nietfeld W; Trendelenburg G
    Biochem Biophys Res Commun; 2007 Aug; 359(3):574-9. PubMed ID: 17548055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
    Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with OPN-305, a humanized anti-Toll-Like receptor-2 antibody, reduces myocardial ischemia/reperfusion injury in pigs.
    Arslan F; Houtgraaf JH; Keogh B; Kazemi K; de Jong R; McCormack WJ; O'Neill LA; McGuirk P; Timmers L; Smeets MB; Akeroyd L; Reilly M; Pasterkamp G; de Kleijn DP
    Circ Cardiovasc Interv; 2012 Apr; 5(2):279-87. PubMed ID: 22354933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRL mice fail to heal the heart in response to ischemia-reperfusion injury.
    Abdullah I; Lepore JJ; Epstein JA; Parmacek MS; Gruber PJ
    Wound Repair Regen; 2005; 13(2):205-8. PubMed ID: 15828946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.
    Zhu M; Feng J; Lucchinetti E; Fischer G; Xu L; Pedrazzini T; Schaub MC; Zaugg M
    Cardiovasc Res; 2006 Oct; 72(1):152-62. PubMed ID: 16901477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice.
    Montecucco F; Lenglet S; Braunersreuther V; Pelli G; Pellieux C; Montessuit C; Lerch R; Deruaz M; Proudfoot AE; Mach F
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1371-7. PubMed ID: 20413731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.